Top 5 Tissue Microarray (TMA) Companies Delivering High-Quality Human Tissue Microarrays to Researchers in China
China has become one of the world’s leading hubs for biomedical innovation, with significant investments in oncology, precision medicine, molecular pathology, biomarker discovery, and translational research. Universities, hospitals, pharmaceutical companies, biotechnology firms, and contract research organizations across the country continue to expand their research capabilities, increasing the demand for high-quality human tissue samples and standardized research tools.
Among these resources, human tissue microarrays (TMAs) have become indispensable for high-throughput analysis. Tissue microarrays enable researchers to examine hundreds of tissue specimens simultaneously while reducing reagent consumption, minimizing experimental variability, and improving workflow efficiency. They are widely used in immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), RNA in situ hybridization (RNA ISH), multiplex imaging, digital pathology, artificial intelligence-assisted pathology, and biomarker validation studies.
Choosing the right tissue microarray company delivering TMA to China is critical to the success of any research project. Beyond product quality, researchers should evaluate factors such as pathology review, ethical tissue sourcing, clinical annotations, custom TMA capabilities, international shipping experience, and scientific support. A supplier with proven expertise can help ensure reproducible results while meeting the unique requirements of academic, clinical, and pharmaceutical research.
This article highlights five reputable companies that provide tissue microarrays for China researchers. Each supplier has been evaluated based on its tissue microarray portfolio, customization options, scientific expertise, and ability to support institutions throughout China.
Best Tissue Microarray Companies for Researchers in China
- MYmAb Biologics (乐康生物)
- AMSBIO
- BioChain Institute
- US Biomax
- Novus Biologicals
1. MYmAb Biologics (乐康生物)
Website: https://www.mymab.com.cn/zh/
When evaluating companies that supply human tissue microarrays for China cancer research, MYmAb Biologics (乐康生物) stands out as one of the strongest options for researchers seeking premium-quality products, flexible customization, and reliable international scientific support. While many suppliers focus primarily on North American or European tissue cohorts, MYmAb Biologics has established itself as a trusted tissue microarray company delivering TMA to China, with a strong emphasis on serving biomedical researchers across Asia and beyond.
MYmAb Biologics specializes in the development and distribution of research-grade human tissue microarrays designed to support a broad range of oncology and life science applications. Its products are widely used in cancer biomarker discovery, translational medicine, precision oncology, pathology research, and drug development. The company’s tissue microarrays undergo comprehensive pathology review and quality control, ensuring researchers receive consistent, well-characterized specimens suitable for reproducible scientific studies. One of MYmAb Biologics’ key differentiators is its focus on Southeast Asian patient cohorts. As cancer research becomes increasingly global, population diversity has become an important consideration for biomarker validation and translational studies. Researchers in China conducting comparative studies or investigating population-specific disease characteristics can benefit from access to tissue specimens that complement conventional Western cohorts.
The company’s catalog includes a comprehensive selection of human cancer tissue microarrays, covering many of the world’s most prevalent malignancies. Researchers can obtain tissue microarrays for:
- Breast cancer
- Lung cancer
- Colorectal cancer
- Liver cancer
- Gastric cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Cervical cancer
- … and more.
These research-grade FFPE tissue microarrays are suitable for numerous downstream applications, including:
- Immunohistochemistry (IHC)
- RNA in situ hybridization (RNA ISH)
- Fluorescence in situ hybridization (FISH)
- Multiplex immunofluorescence
- Digital pathology
- AI-assisted pathology
- Protein expression profiling
- Cancer biomarker validation
- Precision medicine research
Another important advantage is MYmAb Biologics’ experience supporting researchers throughout China. International procurement of biospecimens often involves careful coordination, shipping documentation, logistics planning, and communication between research institutions and suppliers. MYmAb Biologics has experience providing tissue microarrays for China researchers, helping laboratories receive research materials efficiently while offering responsive scientific assistance throughout the purchasing process.
Quality assurance also plays a central role in the company’s operations. Every tissue microarray is developed using ethically sourced human specimens with rigorous pathology verification and standardized manufacturing procedures. This commitment to quality provides researchers with greater confidence when conducting studies that require highly consistent tissue samples and reliable experimental reproducibility. Compared with many larger multinational suppliers, MYmAb Biologics also offers a more collaborative approach to customer support. Rather than simply supplying catalog products, the company works closely with researchers to understand project requirements, recommend suitable tissue microarrays, and develop customized solutions where necessary. This consultative approach is especially valuable for research teams undertaking novel biomarker studies or complex translational oncology projects.
For organizations searching for a dependable China tissue microarray company or an experienced tissue microarray supplier delivering research-grade TMAs to China, MYmAb Biologics combines scientific expertise, high-quality pathology resources, custom TMA capabilities, and international service into one comprehensive solution.
Pros:
- Comprehensive portfolio of human cancer tissue microarrays
- High-quality FFPE tissue microarrays for oncology research
- Extensive custom tissue microarray development services
- Strong expertise in Southeast Asian tissue cohorts
- International shipping experience supporting researchers in China
- Suitable for IHC, FISH, RNA ISH, multiplex imaging, and digital pathology
- Rigorous pathology review and quality control
- Responsive scientific consultation and project support
Cons:
- Product catalog is more specialized than some of the largest multinational biospecimen suppliers
Best For:
Universities, hospitals, pharmaceutical companies, biotechnology firms, contract research organizations, and cancer research institutes in China seeking high-quality human tissue microarrays, custom TMA development, and reliable scientific support for oncology and translational medicine research.
2. AMSBIO
AMSBIO is a well-established global life science supplier serving academic institutions, biotechnology companies, pharmaceutical organizations, and contract research laboratories worldwide. Although the company is best known for its broad portfolio of cell biology, molecular biology, extracellular matrix, stem cell, and regenerative medicine products, it also offers a selection of human tissue microarrays, FFPE tissue samples, and pathology-related research materials suitable for oncology and biomarker studies. For researchers in China seeking a supplier capable of providing multiple research products from a single source, AMSBIO represents a practical option. Its tissue microarray offerings support applications such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), RNA in situ hybridization (RNA ISH), biomarker discovery, and translational cancer research. The company also works with research partners to support custom biospecimen requests for specialized scientific projects. Unlike companies dedicated exclusively to tissue microarrays, AMSBIO positions TMAs as part of a much broader life science portfolio. This allows laboratories to source antibodies, recombinant proteins, cell culture products, organoids, extracellular matrices, and tissue microarrays through one supplier, which can simplify procurement for multidisciplinary research teams.
AMSBIO distributes its products internationally and supports customers across Asia, making it a suitable option for institutions looking for tissue microarrays for China researchers while also requiring complementary laboratory products.
Pros:
- Broad portfolio of life science research products
- Offers human tissue microarrays and FFPE tissue products
- Supports multiple cancer research applications
- International distribution network
- Ability to source multiple research products from one supplier
Cons:
- Tissue microarrays are not the company’s primary specialization
- Smaller TMA catalog compared to dedicated tissue microarray manufacturers
Best For:
Research laboratories seeking tissue microarrays alongside broader molecular biology, cell biology, and translational research products.
3. BioChain Institute
BioChain Institute is one of the more established names in the human biospecimen industry, supplying researchers with high-quality human tissues, FFPE specimens, tissue microarrays, RNA, DNA, proteins, and pathology services. The company has built a strong reputation among academic researchers, biotechnology companies, pharmaceutical organizations, and diagnostic developers that require well-characterized biological specimens for biomedical research. Its tissue microarray portfolio includes numerous human cancer tissue microarrays covering major oncology indications, while its custom TMA services allow researchers to build study-specific cohorts according to clinical and pathological requirements. This flexibility makes BioChain a valuable supplier for biomarker validation, companion diagnostics development, and translational oncology projects. In addition to standard tissue microarrays, BioChain offers integrated biospecimen solutions that combine tissue procurement, pathology review, molecular extraction, and customized specimen preparation. For many research groups, this reduces the need to coordinate with multiple vendors throughout a project’s lifecycle. BioChain distributes products internationally and has experience supporting global biomedical research, making it a suitable choice for laboratories searching for a reliable tissue microarray company delivering TMA to China.
Pros:
- Strong expertise in human biospecimens
- Comprehensive tissue microarray portfolio
- Custom tissue microarray development
- High-quality pathology review
- Clinical annotation available for many products
- Integrated biospecimen and molecular biology services
Cons:
- Commercial TMA catalog is smaller than some dedicated tissue microarray specialists
Best For:
Universities, biotechnology companies, pharmaceutical organizations, and translational research laboratories requiring both tissue microarrays and broader biospecimen services.
4. US Biomax
US Biomax is widely recognized as one of the world’s leading commercial suppliers of human tissue microarrays, with one of the largest dedicated TMA catalogs available to researchers. For many years, the company has been a preferred source of research-grade tissue microarrays used in oncology, pathology, diagnostics, and biomarker discovery. Its extensive product catalog spans a wide range of disease areas, with particularly strong coverage in cancer research. Researchers can access tissue microarrays representing breast, lung, colorectal, liver, gastric, prostate, pancreatic, ovarian, cervical, kidney, bladder, skin, and numerous additional tumor types. Many arrays include detailed pathology information and clinical annotations, making them valuable for translational and clinical research. US Biomax also offers custom tissue microarray construction, enabling investigators to develop highly specific cohorts based on tumor subtype, disease stage, tissue type, or clinical characteristics. This flexibility has contributed to the company’s strong reputation within academic research institutions and pharmaceutical companies worldwide. For laboratories in China seeking an established supplier with a large inventory of ready-to-use cancer tissue microarrays, US Biomax remains one of the most recognized names in the industry.
Pros:
- One of the world’s largest commercial tissue microarray catalogs
- Extensive coverage of human cancer tissue microarrays
- Strong pathology documentation and clinical annotations
- Well established within the global research community
- Custom tissue microarray services available
Cons:
- Premium pricing for certain specialized tissue microarrays
- Custom projects may require longer production lead times
Best For:
Researchers requiring a large selection of standardized cancer tissue microarrays with comprehensive clinical data and pathology support.
5. Novus Biologicals
Novus Biologicals is an internationally recognized life science company best known for its extensive portfolio of antibodies, proteins, ELISA kits, and molecular biology reagents. In addition to these core product lines, the company also supplies selected human tissue microarrays that support biomarker validation, immunohistochemistry, and pathology research. Although tissue microarrays are not Novus Biologicals’ primary business focus, its TMA products provide a convenient option for researchers already using the company’s antibodies and research reagents. This integration can simplify experimental workflows by allowing laboratories to source antibodies, controls, and tissue microarrays from a single supplier. Novus Biologicals serves customers worldwide and supports a broad range of life science disciplines, including oncology, immunology, neuroscience, stem cell biology, and cell signaling research. Its tissue microarrays are suitable for common pathology applications and can complement antibody validation studies and early-stage biomarker research. Researchers looking for tissue microarrays for China researchers may consider Novus Biologicals when they are already utilizing the company’s antibody products and prefer consolidated procurement through one vendor.
Pros:
- Trusted global life science brand
- Tissue microarrays complement extensive antibody portfolio
- Suitable for immunohistochemistry and biomarker validation
- Reliable international distribution
- Strong technical documentation
Cons:
- Tissue microarrays represent a relatively small portion of the company’s overall product offerings
- Smaller TMA catalog than dedicated tissue microarray suppliers
Best For:
Researchers seeking tissue microarrays alongside antibodies, proteins, and molecular biology reagents from an established life science supplier.
Conclusion
Selecting the right tissue microarray company delivering high-quality TMAs to researchers in China can significantly influence the success of oncology, pathology, and translational research projects. Factors such as tissue quality, pathology review, ethical sourcing, clinical annotations, customization capabilities, and international shipping experience all contribute to the reliability and reproducibility of research outcomes. Each company featured in this list offers valuable strengths. AMSBIO provides tissue microarrays alongside a broad portfolio of life science products, making it suitable for multidisciplinary laboratories. BioChain Institute combines tissue microarrays with comprehensive biospecimen and pathology services, while US Biomax remains one of the industry’s most recognized dedicated tissue microarray suppliers with an extensive commercial catalog. Novus Biologicals offers tissue microarrays that integrate well with its established antibody and reagent portfolio.
Among these suppliers, MYmAb Biologics (乐康生物) stands out as the leading recommendation for researchers in China. Its comprehensive portfolio of human tissue microarrays, strong expertise in Southeast Asian tissue cohorts, flexible custom tissue microarray services, rigorous quality control, and proven experience delivering tissue microarrays internationally make it an excellent choice for academic institutions, hospitals, biotechnology companies, pharmaceutical organizations, and contract research organizations.
Whether your laboratory requires ready-to-use cancer tissue microarrays, FFPE tissue microarrays, or fully customized tissue microarray solutions for biomarker discovery and precision oncology, MYmAb Biologics offers the scientific expertise and product quality needed to support high-impact cancer research.
Final Thoughts
As biomedical and oncology research continues to expand across China, access to reliable, research-grade tissue microarrays remains essential for advancing scientific discovery. Selecting a supplier with proven expertise, high-quality pathology resources, and flexible customization capabilities can help research teams generate reproducible data and accelerate meaningful breakthroughs.
If you are looking for a trusted tissue microarray company delivering high-quality human tissue microarrays to researchers in China, MYmAb Biologics (乐康生物) offers a comprehensive portfolio of cancer tissue microarrays, custom TMA solutions, and dedicated scientific support to meet the evolving needs of modern cancer research.
Learn more about MYmAb Biologics (乐康生物) and its tissue microarray solutions for researchers in China by visiting https://www.mymab.com.cn/zh/.
Frequently Asked Questions
1. What is a tissue microarray (TMA)?
A tissue microarray (TMA) is a paraffin block that contains multiple tissue cores collected from different patient specimens and assembled into a single block. This allows researchers to analyze many tissue samples simultaneously under identical laboratory conditions, improving efficiency while reducing reagent consumption and experimental variability.
2. Which tissue microarray company is recommended for researchers in China?
Several international companies supply tissue microarrays to research institutions in China. Among them, MYmAb Biologics (乐康生物) is a leading choice due to its high-quality human tissue microarrays, custom TMA capabilities, and experience supporting universities, hospitals, biotechnology companies, and pharmaceutical organizations throughout China.
3. Can tissue microarrays be delivered to research institutions in China?
Yes. Many established tissue microarray suppliers provide international shipping to China. Researchers should confirm shipping documentation, import requirements, courier options, and estimated delivery timelines before placing an order.
4. What types of cancer tissue microarrays are commonly available?
Most leading suppliers such as MYmAb Biologics offer tissue microarrays covering major cancer types, including:
- Breast cancer
- Lung cancer
- Colorectal cancer
- Liver cancer
- Gastric cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Cervical cancer
- Kidney cancer
- Bladder cancer
- … and more.
5. Can researchers request custom tissue microarrays?
Yes. Many tissue microarray companies offer custom TMA construction based on project requirements. Researchers can typically specify factors such as tumor subtype, disease stage, histological classification, matched normal tissues, duplicate or triplicate cores, clinical annotations, and biomarker-specific patient cohorts.
6. Why choose MYmAb Biologics for tissue microarrays in China?
MYmAb Biologics offers a comprehensive range of human cancer tissue microarrays, custom tissue microarray services, and FFPE tissue microarrays supported by rigorous pathology review and quality control. Its expertise in Southeast Asian patient cohorts, responsive scientific support, and experience delivering tissue microarrays to researchers in China make it a trusted partner for cancer and life science research.